tramadol denk 50 tablets effervescent
losan pharma gmbh - tramadol (tramadol hydrochloride) - tablets effervescent - 50mg
doloforte denk tablets film-coated
denk pharma gmbh & co. kg - tramadol (tramadol hydrochloride), paracetamol - tablets film-coated - 37,5mg+ 325mg
mertenil tablets film-coated
gedeon richter plc - rosuvastatin (rosuvastatin calcium) - tablets film-coated - 20mg
mertenil tablets film-coated
gedeon richter plc - rosuvastatin (rosuvastatin calcium) - tablets film-coated - 10mg
mertenil tablets film-coated
gedeon richter plc - rosuvastatin (rosuvastatin calcium) - tablets film-coated - 5mg
naflusine injection x 100's
fluphenazine decanoate 25mg/ml
flusine 20% wv oral solution
nam pharma sdn. bhd. - tilmicosin -
marynarka 0,075 mg/0,020 mg tabletten
zappp instant hand sanitizer- alcohol gel
lusine industria e comercio de cosmeticos eireli - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease.
docetaxel accord
accord healthcare s.l.u. - docetaxel - head and neck neoplasms, carcinoma, non-small-cell lung, adenocarcinoma, prostatic neoplasms, breast neoplasms - antineoplastic agents, - breast cancerdocetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.docetaxel accord in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.docetaxel accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.docetaxel accord in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer w